Trevena Announces Publication of Results from Phase 3 “Real World” Safety Study for Oliceridine in The Journal of Pain Research

Nov 20, 2019 7:00am EST

Trevena to Present at the Stifel 2019 Healthcare Conference

Nov 18, 2019 5:05pm EST

Trevena Reports Third Quarter 2019 Results and Topline Data From Multi-Dose Healthy Volunteer QT Study

Nov 04, 2019 7:00am EST

Trevena Announces Presentations at the American Society of Anesthesiologists 2019 Annual Meeting

Oct 21, 2019 10:30am EDT

Trevena to Present at the 2019 Cantor Global Healthcare Conference

Sep 27, 2019 7:00am EDT

Trevena to Participate in Upcoming Conferences in September 2019

Sep 03, 2019 7:00am EDT

Trevena Advances NDA Resubmission Activities for Oliceridine

Aug 28, 2019 4:01pm EDT

Trevena Reports Second Quarter 2019 Results

Aug 07, 2019 7:00am EDT

Trevena to Report Second Quarter 2019 Results on August 7, 2019

Jul 31, 2019 7:00am EDT

Trevena Appoints Barry Shin as Chief Financial Officer

Jun 27, 2019 7:00am EDT